- Home
- ELVN vs ALX Comparison
ELVN vs ALX Comparison
Compare ELVN & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- ALX
- Stock Information
- Founded
- ELVN 2016
- ALX 1928
- Country
- ELVN United States
- ALX United States
- Employees
- ELVN N/A
- ALX N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- ELVN Health Care
- ALX Real Estate
- Exchange
- ELVN Nasdaq
- ALX Nasdaq
- Market Cap
- ELVN 927.8M
- ALX 1.2B
- IPO Year
- ELVN 2020
- ALX N/A
- Fundamental
- Price
- ELVN $20.73
- ALX $228.01
- Analyst Decision
- ELVN Strong Buy
- ALX Sell
- Analyst Count
- ELVN 5
- ALX 1
- Target Price
- ELVN $41.20
- ALX $125.00
- AVG Volume (30 Days)
- ELVN 747.2K
- ALX 77.9K
- Earning Date
- ELVN 08-12-2025
- ALX 08-04-2025
- Dividend Yield
- ELVN N/A
- ALX 7.74%
- EPS Growth
- ELVN N/A
- ALX N/A
- EPS
- ELVN N/A
- ALX 7.72
- Revenue
- ELVN N/A
- ALX $219,892,000.00
- Revenue This Year
- ELVN N/A
- ALX N/A
- Revenue Next Year
- ELVN N/A
- ALX N/A
- P/E Ratio
- ELVN N/A
- ALX $30.12
- Revenue Growth
- ELVN N/A
- ALX N/A
- 52 Week Low
- ELVN $13.30
- ALX $184.76
- 52 Week High
- ELVN $30.03
- ALX $251.63
- Technical
- Relative Strength Index (RSI)
- ELVN 52.08
- ALX 61.13
- Support Level
- ELVN $19.22
- ALX $222.50
- Resistance Level
- ELVN $21.90
- ALX $231.23
- Average True Range (ATR)
- ELVN 1.49
- ALX 5.35
- MACD
- ELVN -0.19
- ALX 0.07
- Stochastic Oscillator
- ELVN 39.43
- ALX 91.91
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.